Clinical Trial Update: Paclitaxel and Cisplatin or Topotecan With or Without Bevacizumab in Treating Patients With Stage IVB, Recurrent, or Persistent Cervical Cancer [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating paclitaxel and cisplatin or topotecan with or without bevacizumab in stage IVB, recurrent, or persistent cervical cancer has complete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Adenocarcinoma
• Cervical Adenosquamous Carcinoma
• Cervical Cancer
• Cervical Carcinoma
• Cervical Squamous Cell Carcinoma
• Stage Ivb Cervical Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)
• CISPLATIN (cisplatin)
• PACLITAXEL (PACLITAXEL)
• Topotecan (topotecan)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Cervical Adenocarcinoma, Cervical Adenosquamous Carcinoma | Phase 3 | Status: COMPLETED | Results posted: 2016-05-24